GlassScriptPhysician profile
Yatin Kheti
NPI 1588893994
$9,018.40
in general payments reported to CMS, 2019-2025
15 companies · $5,189 in 2025
The $5,189 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $762 · 2020: $280 · 2021: $212 · 2022: $607 · 2023: $629 · 2024: $1,340 · 2025: $5,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,587 · Education: $2,514 · Travel and Lodging: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,586.63 |
| Education | $2,514.00 |
| Travel and Lodging | $1,057.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,529.81 | 2024-2025 | |
| Glaxosmithkline, LLC. | $1,278.80 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $933.60 | 2019-2024 | Fasenra, Andexxa |
| United Therapeutics Corporation | $483.36 | 2021-2025 | Tyvaso |
| Pulmonx Corporation | $465.25 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Boehringer Ingelheim Pharmaceuticals, INC. | $430.33 | 2022-2025 | Ofev |
| Actelion Pharmaceuticals US, INC. | $312.27 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $175.26 | 2019 | |
| Shionogi INC | $117.87 | 2024 | Fetroja |
| Genzyme Corporation | $114.99 | 2024 | |
| Grifols USA, LLC | $78.80 | 2019 | |
| Medtronic, INC. | $32.75 | 2024 | Illumisite |
| Viatris Specialty LLC | $25.99 | 2025 | Yupelri |
| Edwards Lifesciences Corporation | $20.14 | 2022 | |
| Abiomed | $19.18 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yatin Kheti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.